Skip to content
Inotiv Logo
  • About
    • Why Inotiv
    • Leadership
    • News
    • Events
    • Regulatory Compliance
  • Services
    • Discovery Through Approval
    • In Vivo Services
      • Safety Pharmacology
      • Genetic Toxicology
      • Developmental and Reproductive Toxicology
      • Surgical Models and Medical Device Testing
    • Pharmacology and Toxicology Assessment
    • Histology
    • Pathology
    • Bioanalytical Services
      • Nonregulated Discovery Bioanalysis
      • Regulated Preclinical and Clinical Bioanalysis
    • Drug Metabolism and Pharmacokinetics (DMPK)
    • List of Assays
    • Consulting
  • Insights
  • Contact
  • |
  • Investors
    • Press Room
    • Investor Information
    • SEC Filings
    • Corporate Governance
    • Investor Contacts
  • Careers
  • VISIT OUR VIRTUAL BOOTH

2017

Corporate News

December 12, 2017

BASi Announces Enhanced Bioequivalence Capabilities

Corporate News

November 13, 2017

Steady Growth Spurs Plans for BASi Expansion of GLP Toxicology Facility in Indiana

Get the Insights You Deserve

Answering the right questions on time and with high-quality data is the key to achieving your objectives. Expect more.

Get In Touch
Inotiv Logo

2701 Kent Avenue
West Lafayette, IN 47906 USA
800.845.4246
765.463.4527

Copyright © 2022 Inotiv. All Rights Reserved.

  • Privacy
  • Accessibility
  • Terms Of Use
  • Contact
  • About
    • Why Inotiv
    • Leadership
    • News
    • Events
    • Regulatory Compliance
  • Services
    • Discovery Through Approval
    • In Vivo Services
      • Safety Pharmacology
      • Genetic Toxicology
      • Developmental and Reproductive Toxicology
      • Surgical Models and Medical Device Testing
    • Pharmacology and Toxicology Assessment
    • Histology
    • Pathology
    • Bioanalytical Services
      • Nonregulated Discovery Bioanalysis
      • Regulated Preclinical and Clinical Bioanalysis
    • Drug Metabolism and Pharmacokinetics (DMPK)
    • List of Assays
    • Consulting
  • Insights
  • Contact
  • |
  • Investors
    • Press Room
    • Investor Information
    • SEC Filings
    • Corporate Governance
    • Investor Contacts
  • Careers
  • VISIT OUR VIRTUAL BOOTH